FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+12.57%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.28B
AUM Growth
+$1.28B
(+15%)
Cap. Flow
+$79.4M
Cap. Flow
% of AUM
6.22%
Top 10 Holdings %
Top 10 Hldgs %
52.86%
Holding
80
New
6
Increased
21
Reduced
22
Closed
1
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$26.5M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$21.4M |
| 3 |
TELA Bio
TELA
|
$17.5M |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
$16.3M |
| 5 |
Outset Medical
OM
|
$13.9M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$21.7M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$15.8M |
| 3 |
Krystal Biotech
KRYS
|
$11.1M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$7.57M |
| 5 |
Keros Therapeutics
KROS
|
$7.12M |
Sector Composition
| 1 | Healthcare | 94.83% |
| 2 | Communication Services | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKU
76
DELISTED
Akumin Inc. Common Stock (DE)
AKU
| $284K | 0.02% |
1,575,098
-1,964,400
| -55% | -$354K |
|
77
Organon & Co
OGN
$2.56B
| $265K | 0.02% |
12,716
| – | – |
|
78
Revvity
RVTY
$9.68B
| $264K | 0.02% |
2,223
| – | – |
|
|
SYNH
79
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $242K | 0.02% |
5,736
| – | – |
|
|
BLU
80
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-3,020,393
| Closed | -$21.7M |
|